Why does Gas6 but not ProS1 promote microglia efferocytosis despite both being TAM receptor ligands?

OPEN

The study shows Gas6 promotes efferocytosis while ProS1 does not, despite both being established TAM receptor ligands. This selectivity is unexplained and critical for understanding therapeutic targeting of efferocytosis in neuroinflammation. Gap type: unexplained_observation Source paper: Gas6 Promotes Microglia Efferocytosis and Suppresses Inflammation Through Activating Axl/Rac1 Signaling in Subarachnoid Hemorrhage Mice. (2023, Translational stroke research, PMID:36324028)

Priority: 0.84 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why does Gas6 but not ProS1 promote microglia efferocytosis despite both being TAM receptor ligands? is a 0.84 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why does Gas6 but not ProS1 promote microglia efferocytosis despite both being TAM receptor ligands? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

co associated with (1)

GAS6/TAM receptor complexTAM
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps